Expression of tumor necrosis factor-alpha--converting enzyme and tumor necrosis factor-alpha in human myocarditis.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of the American College of Cardiology

• Publication date

  2000-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0735-1097(00)00827-5PMID 11028485
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor necrosis factor-a converting enzyme

  2002cited by this paper
• Molecular aspects of myocarditis

  2000cited by this paper
• Tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy.

  1999cited by this paper
• Tumor Necrosis Factor-α–Converting Enzyme and Tumor Necrosis Factor-α in Human Dilated Cardiomyopathy

  1999cited by this paper
• Pro-Tumor Necrosis Factor-α Processing Activity Is Tightly Controlled by a Component That Does Not Affect Notch Processing*

  1998cited by this paper
• Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α

  1998cited by this paper
• Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha.

  1998cited by this paper
• Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats.

  1998cited by this paper
• Real-time quantitative RT–PCR after laser-assisted cell picking

  1998cited by this paper
• Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme.

  1998cited by this paper
• Molecular aspects of myocarditis.

  1998cited by this paper
• A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells

  1997influential reference
• Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy.

  1997cited by this paper
• Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha.

  1997cited by this paper
• Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α

  1997cited by this paper
• Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α

  1997cited by this paper
• Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus B3

  1997cited by this paper
• A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

  1997cited by this paper
• A novel method for real time quantitative RT-PCR.

  1996cited by this paper
• Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart.

  1996cited by this paper
• Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy

  1996cited by this paper
• Persistent expression of cytokine in the chronic stage of viral myocarditis in mice.

  1996cited by this paper
• Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy.

  1996cited by this paper
• Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart

  1996cited by this paper
• Enteroviral RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy

  1995cited by this paper
• Restricted usage of T cell receptor V alpha-V beta genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy.

  1995cited by this paper
• Enteroviraf RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy

  1994cited by this paper
• Processing of tumour necrosis factor-alpha precursor by metalloproteinases.

  1994cited by this paper
• Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

  1994cited by this paper
• Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

  1993cited by this paper
• Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions.

  1991cited by this paper
• Myocyte Injury and Contraction Abnormalities Produced by Cytotoxic T Lymphocytes

  1991cited by this paper
• Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

  1990cited by this paper
• Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene.

  1988influential reference
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Myocarditis. A histopathologic definition and classification.

  1987cited by this paper
• Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy.

  1986cited by this paper
• Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor

  1985cited by this paper
• Tumor necrosis factor (TNF).

  1985cited by this paper
• Viral myocarditis. A review.

  1980cited by this paper
• Viral myocarditis. A review.

  1980cited by this paper

• Therapeutic Potential of Holothuria leucospilota Extract in STZ‐Induced Diabetic Rats: Targeting Inflammation and Apoptosis at the Gene Expression Level

  2026cites this paper
• Assessing the toxicological effects of exposure to environmental pollutants PET-MPs on vascular diseases: insights from network toxicology, molecular docking, molecular dynamics, and experimental validation.

  2025cites this paper
• Therapeutic Potential of Qilianxiaopi Formula: Targeting ADAM17-Mediated Chronic Inflammation in Atrophic Gastritis

  2025cites this paper
• Dihydrotanshinone I improves cardiac function by promoting lymphangiogenesis after myocardial ischemia-reperfusion injury.

  2025cites this paper
• Estradiol mitigates stress-induced cardiac injury and inflammation by downregulating ADAM17 via the GPER-1/PI3K signaling pathway

  2023cites this paper
• The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond

  2023cites this paper
• The Cytokine CX3CL1 and ADAMs/MMPs in Concerted Cross-Talk Influencing Neurodegenerative Diseases

  2023cites this paper
• Cardiomyocyte cohesion is increased after ADAM17 inhibition

  2023cites this paper
• TNF-α protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells

  2023cites this paper
• Blood-Derived Exosomes With Anti-Inflammatory Properties As A New Minimally Invasive Intratesticular Therapy For Aflatoxin B1-Associated Chronic Testopathy

  2023influential citation
• The Role of ADAM17 in Inflammation-Related Atherosclerosis

  2022cites this paper
• ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

  2022cites this paper
• The Synergy of ADAM17-Induced Myocardial Inflammation and Metabolic Lipids Dysregulation During Acute Stress: New Pathophysiologic Insights Into Takotsubo Cardiomyopathy

  2021cites this paper
• ADAM17, A Key Player of Cardiac Inflammation and Fibrosis in Heart Failure Development During Chronic Catecholamine Stress

  2021influential citation
• β1-adrenergic receptor N-terminal cleavage by ADAM17; the mechanism for redox-dependent downregulation of cardiomyocyte β1-adrenergic receptors.

  2021cites this paper
• Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19

  2020cites this paper
• ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19

  2020cites this paper
• Tumor necrosis factor-α: Molecular assessment of gene expression, genetic variants and serum level in Egyptian patients with knee osteoarthritis

  2020cites this paper
• Brain TACE (Tumor Necrosis Factor-α-Converting Enzyme) Contributes to Sympathetic Excitation in Heart Failure Rats.

  2019cites this paper
• Degradome of soluble ADAM10 and ADAM17 metalloproteases

  2019cites this paper
• The renin-angiotensin system: going beyond the classical paradigms

  2019cites this paper
• Potential role of a disintegrin and metalloproteinase-17 (ADAM17) in age-associated ventricular remodeling of rats

  2019cites this paper
• Toll-like Receptors Signaling Pathways as a Potential Therapeutic Target in Cardiovascular Disease.

  2018cites this paper
• Investigating known and novel biomarkers for risk stratification in cardiovascular disease

  2018influential citation
• Association of MiRNA122 & ADAM17 with Lipids among Hypertensives in Nigeria

  2018cites this paper
• Role of tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and associated proteins in coronary artery disease and cardiac events.

  2017influential citation
• Diseases of the Intercalated Disc

  2017cites this paper
• Effect of hyperglycemia and thiazolidinediones on cardiac angiotensin converting enzyme 2 (ACE2) and neprilysin (NEP) in db/db diabetic mice.

  2017cites this paper
• Usefulness of Subepicardial Hyperemia on Contrast-Enhanced First-Pass Magnetic Resonance Perfusion Imaging for Diagnosis of Acute Myocarditis.

  2016cites this paper
• Nicotine inhibits the production of proinflammatory cytokines of mice infected with coxsackievirus B3.

  2016cites this paper
• Drugs Targeting the Canonical NF-κB Pathway to Treat Viral and Autoimmune Myocarditis.

  2016cites this paper
• Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3

  2015cites this paper
• The Role of Peripheral Biomarkers of Humoral Immunity in Diagnosis of Inflammatory Cardiomyopathy and Their Comparison with the Data of the EMB

  2015cites this paper
• Erratum: Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3

  2015cites this paper
• Cardiomyocyte A Disintegrin And Metalloproteinase 17 (ADAM17) Is Essential in Post–Myocardial Infarction Repair by Regulating Angiogenesis

  2015cites this paper
• Targeting CD13 (aminopeptidase-N) in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cells

  2014cites this paper
• Exposure of cardiac microvascular endothelial cells to harmful stimuli : a study of the cellular responses and mechanisms

  2014cites this paper
• Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis

  2013cites this paper
• Increased Levels of Plasma Soluble Sema4D in Patients with Heart Failure

  2013cites this paper
• Chronic inflammatory cardiomyopathy of interferon γ-overexpressing transgenic mice is mediated by tumor necrosis factor-α.

  2012cites this paper
• Comparison of Effects of Ivabradine versus Carvedilol in Murine Model with the Coxsackievirus B3-Induced Viral Myocarditis

  2012cites this paper
• Discrimination and evaluation of lactoferrin and delta-lactoferrin gene expression levels in cancer cells and under inflammatory stimuli using TaqMan real-time PCR

  2010cites this paper
• ADAM-17: the enzyme that does it all

  2010cites this paper
• Inhibition of lung cancer cell proliferation by CD40 signaling through tumor necrosis factor I.

  2009cites this paper
• ADAM17 as a therapeutic target in multiple diseases.

  2009cites this paper
• Immune modulation: Role of the inflammatory cytokine cascade in the failing human heart

  2008cites this paper
• Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study.

  2008cites this paper
• Differential regulation of tumor necrosis factor-α-converting enzyme and angiotensin-converting enzyme by type I and II interferons in human normal and leukemic myeloid cells

  2007cites this paper
• Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis.

  2006cites this paper
• Myocardites aiguës et subaiguës

  2006cites this paper
• Epidemiology of congestive heart failure: general considerations

  2005cites this paper
• Effects of carvedilol treatment on cardiac cAMP 1 response element binding protein expression and 2 phosphorylation in acute coxsackievirus B 3induced 3induced 3induced 3 myocarditis

  2005cites this paper
• Cardiac remodeling and failure: from molecules to man (Part I).

  2005cites this paper
• Cardiac remodeling and failure: from molecules to man (Part III).

  2005cites this paper
• Disruptions and detours in the myocardial matrix highway and heart failure

  2005cites this paper
• Tumor Necrosis Factor α Polymorphism in Heart Failure/Cardiomyopathy

  2004cites this paper
• Tumor necrosis factor alpha polymorphism in heart failure/cardiomyopathy.

  2004cites this paper
• Overexpression of tumor necrosis factor (TNF)alpha and TNFalpha receptor I in human viral myocarditis: clinicopathologic correlations.

  2004cites this paper
• Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis?

  2004cites this paper
• Overexpression of tumor necrosis factor (TNF)α and TNFα receptor I in human viral myocarditis: clinicopathologic correlations

  2004cites this paper
• Increased mRNA expression of tumour necrosis factor-alpha and its converting enzyme in circulating leucocytes of patients with acute myocardial infarction.

  2003cites this paper
• Cardiomyocytes overexpressing TNF‐α attract migration of embryonic stem cells via activation of p38 and c‐Jun amino‐terminal kinase

  2003cites this paper
• The role of anticytokine therapy in heart failure: recent lessons from preclinical and clinical trials?

  2003cites this paper
• Expression of Toll-like receptor 4 is associated with enteroviral replication in human myocarditis.

  2003cites this paper
• Tumor necrosis factor-α in cardiovascular biology and the potential role for anti-tumor necrosis factor-α therapy in heart disease

  2002cites this paper
• Oxygen free radicals and heart failure: new insight into an old question.

  2002cites this paper
• The active site of a zinc-dependent metalloproteinase influences the computed pK(a) of ligands coordinated to the catalytic zinc ion.

  2002cites this paper
• Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease.

  2002cites this paper
• Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).

  2001cites this paper
• The role of tumor necrosis factor in cardiac disease.

  2001cites this paper
• Methimazole Interferes with the Progression of Experimental Autoimmune Myocarditis in Rats

  2001cites this paper
• Myocardites aiguës et subaiguës

  2001cites this paper
• Chronic Inflammatory Cardiomyopathy of Interferon (cid:1) –Overexpressing Transgenic Mice Is Mediated by Tumor Necrosis Factor-(cid:2)

  year unknowncites this paper